October 27, 2015 GSK hopes big clinical trial can breathe new life into lung drug GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result.
October 27, 2015 Newly approved drug restores lung function in woman with life-threatening disease A young woman diagnosed with a hard-to-treat, rare lung disease has found an unexpected solution in the form of a drug originally designed to prevent organ rejection in kidney transplant patients.
October 27, 2015 Vulnerable populations often miss cancer warning signs Some of society’s most vulnerable citizens are also most likely to overlook cancer warning signs, a new U.K. study suggests.
October 27, 2015 50 years of tobacco control extended lives of 8 million Americans, study claims A new study has concluded that the surgeon general’s report, along with various other tobacco control efforts, have significantly extended the lives of 8 million Americans – adding nearly 20 years to their life expectancy.
October 27, 2015 Lung cancer now top cancer killer for women in rich nations For the first time, lung cancer has passed breast cancer as the leading cause of cancer deaths for women in rich countries.
October 27, 2015 Cigars just as harmful to health as cigarettes, study says Cigar smokers are thought to inhale less smoke than cigarette smokers, leading some people to believe they pose fewer health risks than cigarettes.
October 27, 2015 Cancer risk above 50 percent for Brits born in 1960 More than half of people born after 1960 in the U.K. may be diagnosed with some form of cancer in their lifetimes, a new estimate suggests.
October 27, 2015 Cancer surge in China prompts rise of special patient hotels Li Xiaohe has set herself up for the long haul in a cramped but sunny room in western Beijing, about a block from China's most renowned cancer hospital.
October 27, 2015 Hospitalization rates in chemo trials may be misleading Cancer patients need to be prepared for serious side effects from chemotherapy, and hospitalization is one that happens much more often in the real world than in drug trials, according to a new study.
October 27, 2015 AstraZeneca lung cancer drug delays disease by more than a year An experimental lung cancer pill from AstraZeneca delays disease progression by more than a year, according to new data presented at a medical meeting on Friday.
